News for Healthier Living

A Groundbreaking New Approach to Treating Chronic Abdominal Pain

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions such as irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD), which affect millions of people worldwide. The research results were recently published in the international edition of the renowned journal Angewandte Chemie.

November 22, 2024


November 25 2024

November 24 2024

November 23 2024

November 22 2024

November 21 2024

November 20 2024

November 19 2024

November 18 2024

November 17 2024

November 16 2024

November 15 2024

November 14 2024

November 13 2024

November 12 2024

November 11 2024